<DOC>
	<DOCNO>NCT01069302</DOCNO>
	<brief_summary>The purpose study evaluate effect high dose clopidogrel antiplatelet therapy inhibition platelet aggregation Japanese patient schedule percutaneous coronary intervention due ischemic heart disease .</brief_summary>
	<brief_title>Clopidogrel High Dose Evaluation Patient With Coronary Artery Disease Japan</brief_title>
	<detailed_description>Dual antiplatelet therapy aspirin thienopyridine use prevent stent thrombosis percutaneous coronary intervention ( PCI ) . Clopidogrel popular thienopyridine . Following 300mg clopidogrel load dose ( LD ) first day , patient take 75mg maintenance dose ( MD ) inhibit platelet aggregation coronary stent implantation . 600mg high LD inhibit platelet aggregation rapidly strongly standard LD prevent thrombotic event around PCI . Similarly high MD inhibit platelet aggregation strongly . Interindividual variability clopidogrel anti-platelet effect report . In Japanese , many non hyporesponders clopidogrel compare Western population . The purpose study evaluate effect high dose clopidogrel antiplatelet therapy inhibition platelet aggregation Japanese patient schedule PCI due ischemic heart disease .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Patients schedule percutaneous coronary intervention due ischemic heart disease Patients take aspirin 81100mg least 1 week . Patients ST elevation myocardial infarction Patients contraindication aspirin clopidogrel Patients take warfarin Patients receive thrombolytic therapy within 2 week Patients take antiplatelet agent except aspirin within 1 month Patients take corticosteroid . Patients take proton pump inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Coronary artery disease</keyword>
</DOC>